The contribution of epidemiology to defining the most appropriate approach to genetic research on schizophrenia

Epidemiologia e Psichiatria Sociale

Volumn 18, Issue 2, 2009, Pages 81-90

  Tosato, Sarah ^a   Lasalvia, Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; GENETICS; HUMAN; MEDICAL RESEARCH; SCHIZOPHRENIA;

BIOMEDICAL RESEARCH; HUMANS; SCHIZOPHRENIA;

EID: 70449715994     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1121189x00000932     Document Type: Review

References (122)

1. Alkelai A., Baum A., Carless M., Crowley J., Dasbanerjee T., Dempster E., Docherty S., Hare E., Galsworthy M.J., Grover D., Glubb D., Karlsson R., Mill J., Sen S., Quinones M.P., Vallender E.J., Verma R., Vijayan N.N., Villafuerte S., Voineskos A.N., Volk H., Yu L., Zimmermann P. & DeLisi L.E. (2008). The XVth World Congress of Psychiatric Genetics, October 7-11, 2007: Rapporteur summaries of oral presentations. American Journal of Medical Genetics B Neuropsychiatry and Genetics 147B, 233-277. (Pubitemid 351355286)
2. Allardyce J., Gacbel W., Zielasek J. & Van Os J. 2007. Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psy-chosis. Schizophrenia Bulletin 33, 863-867. (Pubitemid 47216652)
3. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E. & Bertram. L. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizo-phrenia: the SzGene database. Nature Genetics 40, 827-834. (Pubitemid 351913655)
4. Andreasen N.C. & Olsen S. (1982). Negative v positive schizophrenia. Definition and validation. Archives of General Psychiatry 39, 789-794. (Pubitemid 12090302)
5. Andreasen N.C., Nopoulos P., Schultz S., Miller D., Gupta S., Swayze V. & Flaum M. (1994). Positive and negative symptoms of schizophrenia: past, present, and future. Acta Psychiatrica Scandinavica, Suppl 384, 51-59. (Pubitemid 24356888)
6. Baron M., Gruen R., Asnis L. & Kane J. (1982). Schizoaffective ill-ness, schizophrenia and affective disorders: morbidity risk and genetic transmission. Acta Psychiatrica Scandinavica 65, 253-262. (Pubitemid 12149565)
7. Bleuler E. (1911). Dementia praecox oder die Gruppe der Schizophrenien. In Handbuch der Psychiatrie (ed. G. Aschaffenburg). Deuticke: Leipzig.
8. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K. & Harvey P.D. (2006). Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. American Journal of Psychiatry 163, 418-425. (Pubitemid 44469383)
9. Bowie C.R., Leung W.W., Reichenberg A., McClure M.M., Patterson T.L., Heaton R.K. & Harvey P.D. (2008). Predicting schiz-ophrenia patients' real-world behavior with specific neuropsycho-logical and functional capacity measures. Biological Psychiatry 63, 505-511. (Pubitemid 351220787)
10. Boydell J., Van Os J., McKenzie K., Allardyce J., Goel R., McCreadie R.G. & Murray R.M. (2001). Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. British Medical Journal 323, 1336-1338. (Pubitemid 33152211)
11. Breen G., Prata D., Osborne S., Munro J., Sinclair M., Li T., Staddon S., Dempster D., Sainz R., Arroyo B., Kerwin R.W., St Cloud D. & Collier D. (2006). Association of the dysbindin gene with bipolar affective disorder. American Journal of Psychiatry 163, 1636-1638. (Pubitemid 44465766)
12. Brown A.S., Cohen P., Harkavy-Friedman J., Babulas V., Malaspina D., Gorman J.M. & Susser E.S. (2001). A.E. Bennett. Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biological Psychiatry 49, 473-486.
13. Brown A.S., Schaefer C.A., Quesenberry C.P., Jr., Liu L., Babulas V.P. & Susser E.S. (2005). Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. American Journal Psychiatry 162, 767-773. (Pubitemid 40489141)
14. Cannon M., Jones P.B. & Murray R.M. (2002). Obstetric complica-tions and schizophrenia: historical and meta-analytic review. American Journal of Psychiatry 159, 1080-1092. (Pubitemid 34743246)
15. Cardno A.G. & Farmer A.E. (1995). The case for or against hetero-geneity in the etiology of schizophrenia. The genetic evidence. Schizophrenia Research 17, 153-159.
16. Cardno A.G. & Gottesman I.I. (2000). Twin studies of schizophre-nia: from bow-and-arrow concordances to star wars Mx and functional genomics. American Journal of Medical Genetics 97, 12-17.
17. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., Venturi P., Jones L.A., Lewis S.W., Sham P.C., Gottesman I.I., Farmer A.E., McGuffin P., Reveley A.M. & Murray R.M. (1999). Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Archives of General Psychiatry 56, 162-168. (Pubitemid 29081391)
18. Cardno A.G., Rijsdijk F.V., Sham P.C., Murray R.M. & McGuffin P. (2002). A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry 159, 539-545. (Pubitemid 34274934)
19. Carpenter W.T., Jr., Buchanan R.W., Kirkpatrick B., Tamminga C. & Wood F. (1993). Strong inference, theory testing, and the neu-roanatomy of schizophrenia. Archives of General Psychiatry 50, 825-831. (Pubitemid 23303104)
20. Caspi A. & Moffitt T.E. (2006). Gene-environment interactions in psychiatry: joining forces with neuroscience. Nature Reviews. Neuroscience 7, 583-590. (Pubitemid 43995433)
21. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R. & Craig I.W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57, 1117-1127. (Pubitemid 40615773)
22. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A. & Poulton R. (2003). Influence of life stress on depression: moderation by a poly-morphism in the 5-HTT gene. Science 301, 386-389. (Pubitemid 36877077)
23. Cooper C., Morgan C., Byrne M., Dazzan P., Morgan K., Hutchinson G., Doody G.A., Harrison G., Leff J., Jones P., Ismail K., Murray R., Bebbington P. & Fearon P. (2008). Perceptions of disad-vantage, ethnicity and psychosis. British Journal of Psychiatry 192, 185-190.
24. Craddock N. & Owen M.J. (2007). Rethinking psychosis: the disad-vantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6, 84-91.
25. Craddock N., O'Donovan M.C. & Owen M.J. (2006). Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosol-ogy. Schizophrenia Bulletin 32, 9-16. (Pubitemid 43063811)
26. Craddock N., O'Donovan M.C. & Owen M.J. (2008). Genome-wide association studies in psychiatry: lessons from early studies of non-psy-chiatric and psychiatric phenotypes. Molecular Psychiatry 13, 649-653. (Pubitemid 351861534)
27. Crow T.J. (2008). The emperors of the schizophrenia polygene have no clothes. Psychological Medicine 38, 1681-1685.
28. Davidson L. & McGlashan T. H.. (1997). The varied outcomes of schizophrenia. Canadian Journal of Psychiatry 42, 34-43.
29. DeRosse P., Funke B., Burdick K.E., Lencz T., Ekholm J.M., Kane J.M., Kucherlapati R. & Malhotra A.K. (2006a). Dysbindin genotype and negative symptoms in schizophrenia. American Journal of Psychiatry 163, 532-534. (Pubitemid 44469399)
30. Derosse P., Funke B., Burdick K.E., Lencz T., Goldberg T.E., Kane JM., Kucherlapati R. & Malhotra A.K. (2006b). COMT geno-type and manic symptoms in schizophrenia. Schizophrenia Research 87, 28-31. (Pubitemid 44428127)
31. DeRosse P., Hodgkinson CA., Lencz T., Burdick K.E., Kane J.M., Goldman D. & Malhotra A.K. (2007). Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biological Psychiatry 61, 1208-1210. (Pubitemid 46669457)
32. DeRosse P., Lencz T., Burdick K.E., Siris S.G., Kane J.M. & Malhotra A.K. (2008). The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia. Schizophrenia Bultetin 34, 1047-1053.
33. Detera-Wadleigh S.D. & McMahon F.J. (2006). G72/G30 in schiz-ophrenia and bipolar disorder: review and meta-analysis. Biological Psychiatry 60, 106-114. (Pubitemid 44026593)
34. Dickinson D., Bellack A.S. & Gold J.M. (2007). Social/communi-cation skills, cognition, and vocational functioning in schizophrenia. Schizophrenia Bulletin 33, 1213-1220. (Pubitemid 47347910)
35. Dollfus S. & Everitt B. (1998). Symptom structure in schizophrenia: two-, three- or four-factor models? Psychopathology 31, 120-130.
36. Eaton W.W., Thara R., Federman B., Melton B. & Liang K.Y. (1995). Structure and course of positive and negative symptoms in schizophrenia. Archives of General Psychiatry 52, 127-134.
37. Emsley R., Chiliza B. & Schoeman R. (2008). Predictors of long-term outcome in schizophrenia. Current Opinion in Psychiatry 21, 173-177.
38. Fanous A.H., Neale M.C., Straub R.E., Webb B.T., O'Neill. A.F., Walsh D. & Kendler K.S. (2004). Clinical features of psychotic disor-ders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 125B, 69-78. (Pubitemid 38141407)
39. Fanous A.H., van den Oord E.J., Riley B.P., Aggen S.H., Neale M.C., O'Neill F.A., Walsh D. & Kendler K.S. (2005). Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. American Journal of Psychiatry 162, 1824-1832. (Pubitemid 41428611)
40. Funke B., Finn C.T., Piocik A.M., Lake S., DeRosse P., Kane J.M., Kucherlapati. R. & Malhotra A.K. (2004). Association of the DTNBPl locus with schizophrenia in a U.S. population. American Journal of Human Genetics 75, 891-898. (Pubitemid 39390497)
41. Geddes J.R., Verdoux H., Takei N., Lawrie S.M., Bovet P., Eagles J.M., Heun R., McCreadie R.G., McNeil T.F., O'Callaghan E., Stober G., Willinger U. & Murray R.M. (1999). Schizophrenia and complica-tions of pregnancy and labor: an individual patient data meta-analysis. Schizophrenia Bulletin 25, 413-423.
42. Gershon E.S., DeLisi L.E., Hamovit J., Nurnberger J.I., Jr., Maxwell M.E., Schreiber J., Dauphinais D., Dingman C.W. & Guroff J.J. (1988). A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Archives of General Psychiatry 45, 328-336.
43. Glatt S.J., Faraone S.V. & Tsuang M.T. (2003). Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry 160, 469-476.
44. Green E.K., Raybould R., Macgregor S., Gordon-Smith K., Heron J., Hyde S., Grozeva D., Hamshere M., Williams N., Owen M.J., O'Donovan M.C., Jones L., Jones I., Kirov G. & Craddock N. (2005). Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Archives of General Psychiatry 62, 642-648. (Pubitemid 40973439)
45. Harrison G. (2004). Trajectories of psychosis: towards a new social biology of schizophrenia. Epidemiologia e Psichiatria Sociale 13, 152-157.
46. Harvey PD., Koren D., Reichenberg A. & Bowie C.R. (2006). Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophrenia Bulletin 32, 250-258.
47. Hegarty J.D., Baldessarini R.J., Tohen M., Waternaux C & Oepen G. (1994). One hundred years of schizophrenia: a meta-analysis of the outcome literature. American Journal of Psychiatry 151, 1409-1416. (Pubitemid 24301683)
48. Hennah W., Varilo T., Kestila M., Paunio T., Arajarvi R., Haukka J., Parker A., Martin R., Levitzky S., Partonen T., Meyer .T., Lonnqvist J., Peltonen L. & Ekelund J. (2003). Haplotype transmis-sion analysis provides evidence of association for DISC1 to schizo-phrenia and suggests sex-dependent effects. Human Molecular Genetics 12, 3151-3159. (Pubitemid 37508886)
49. Henquet C., Di Forti M., Morrison P., Kuepper R. & Murray R.M. (2008). Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin 34, 1111-1121.
50. Herken H. & Erdal M.E. (2001). Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatric Genetics 11, 105-109. (Pubitemid 32686191)
51. Hijman R., Hulshoff Pol H.E., Sitskoorn M.M. & Kahn R.S. (2003). Global intellectual impairment does not accelerate with age in patients with schizophrenia: a cross-sectional analysis. Schizophrenia Bulletin 29, 509-517. (Pubitemid 37339385)
52. Hyde TM., Nawroz S., Goldberg T.E., Bigelow L.B., Strong D., Ostrem J.L., Weinberger D.R. & Kleinman .I.E. (1994). Is there cogni-tive decline in schizophrenia? A cross-sectional study. British Journal of Psychiatry 164, 494-500. (Pubitemid 24141675)
53. Ivleva E., Thaker G, & Tamminga C.A. (2008). Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophrenia Bulletin 34, 734-742. (Pubitemid 351957570)
54. Jablensky A. (2006). Subtyping schizophrenia: implications for genetic research. Molecular Psychiatry 11, 815-836.
55. Jobe T.H. & Harrow M. (2005). Long-term outcome of patients with schizophrenia: a review. Canadian Journal of Psychiatry 50, 892-900. (Pubitemid 43161743)
56. Jones P. & Cannon M. (1998). The new epidemiology of schizo-phrenia. Psychiatric Clinics of North America 21, 1-25.
57. Kay S.R. & Sevy S. (1990). Pyramidical model of schizophrenia. Schizophrenia Bulletin 16, 537-545.
58. Kendler KS., Karkowski L.M. & Walsh D. (1998). The structure of psychosis: latent class analysis of probands from the Roscommon Family Study. Archives of General Psychiatry 55, 492-499.
59. Kennedy J.L., Farrer L.A., Andreasen N.C., Mayeux R. & St George-Hyslop P. (2003). The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302, 822-826. (Pubitemid 37339615)
60. Kirkbride J.B., Fearon P., Morgan C., Dazzan P., Morgan K., Tarrant J., Lloyd T., Holloway J., Hutchinson G., Leff J.P., Mallett R.M., Harrison G.L., Murray R.M. & Jones P.B. (2006). Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Archives of General Psychiatry 63, 250-258. (Pubitemid 43345348)
61. Kohn Y., Danilovich E., Filon D., Oppenheim A., Karni O., Kanyas K., Turetsky N., Korner M. & Lerer B. (2004). Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysis. American Journal of Medical Genetics, Part B. Neuropsychiatric Genetics 128B, 65-70. (Pubitemid 38849921)
62. Lasalvia A., Bonetto C., Cristofalo D., Tansella M. & Ruggeri M. (2007a). Predicting clinical and social outcome of patients attending 'real world' mental health services: a 6-year multi-wave follow-up study. Acta Psychiatrica Scandinavica, Suppl. 437, 16-30.
63. Lasalvia A., Bonetto C., Salvi G., Bissoli S., Tansella M. & Ruggeri M. (2007b). Predictors of changes in needs for care in patients receiv-ing community psychiatric treatment: a 4-year follow-up study. Acta Psychiatrica Scandinavica, Suppl. 437, 31.-41. (Pubitemid 350029199)
64. Lenzenweger M.F., Dworkin R.H. & Wethington E. (1991). Examining the underlying structure of schizophrenic phenomenolo-gy: evidence for a three-process model. Schizophrenia Bulletin 17, 515-524.
65. Li T., Zhang F., Liu X., Sun X., Sham PC, Crombie C., Ma X., Wang Q., Meng H., Deng W., Yates P., Hu X., Walker N., Murray R.M., St Cloud D. & Collier D.A. (2005). Identifying potential risk hap-lotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish, populations. Molecular Psychiatry 10, 1037-1044. (Pubitemid 41541989)
66. Liddle P.F. (1987). The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. British Journal of Psychiatry 151, 145-151. (Pubitemid 17102086)
67. Lindenmayer J. P., Bernstein-Hyman R. & Grochowski S. (1994). Five-factor model of schizophrenia. Initial validation. Journal of Nervous and Mental Disease 182, 631-638.
68. Lysaker P. & Bell M. (1995). Negative symptoms and vocation-al impairment in schizophrenia: repeated measurements of work performance over six months. Acta Psychiatrica Scandinavica 91, 205-208.
69. Maier W., Lichtermann D., Minges J., Hallmayer J., Heun R., Benkert O. & Levinson D.F. (1993). Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Archives of General Psychiatry 50, 871-883. (Pubitemid 23330979)
70. Maier W., Hofgen B., Zobel A. & Rietschel M. (2005). Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes? European Archives of Psychiatry and Clinical Neuroscience 255, 159-166. (Pubitemid 40922938)
71. Malaspina D., Harlap S., Fennig S., Heřman D., Nahon D., Feldman D. & Susser E.S. (2001). Advancing paternal age and the risk of schiz-ophrenia. Archives of General Psychiatry 58, 361-367. (Pubitemid 32299532)
72. Malla AK., Norman R.M., Williamson P., Cortese L. & Diaz F. (1993). Three syndrome concept of schizophrenia. A factor analytic study. Schizophrenia Research 10, 143-150. (Pubitemid 23273367)
73. McClay J.L., Fanous A., van den Oord EJ., Webb B.T., Walsh D., O'Neill F.A., Kendler K.S. & Chen X. (2006). Catechol-O-methyltransferase and the clinical features of psychosis. American Journal of Medical Genetics, Part B. Neuropsychiatric Genetics 141B, 935-938.
74. McGrath J. (2008). Hypotheses desert us, while data defend us. Schizophrenia Research 102, 27-28.
75. McGrath. J., Saha S., Welham J., El Saadi O., MacCauley C & Chant D. (2004). A systematic review of the incidence of schizophre-nia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2, 13. (Pubitemid 39111865)
76. Meehl P.E. (1995). Bootstraps taxometrics. Solving the classi-fication problem in psychopathology. American Psychology 50, 266-275.
77. Mockler D., Riordan J. & Sharma T. (1997). Memory and intellec-tual deficits do not decline with age in schizophrenia. Schizophrenia Research 26, 1-7. (Pubitemid 27372052)
78. Mortensen PB., Pedersen C.B., Meibye M., Mors O. & Ewald H. (2003). Individual and familial risk factors for bipolar affective disor-ders in Denmark. Archives of General Psychiatry 60, 1209-1215. (Pubitemid 37494074)
79. Munafo M.R., Bowes L., Clark T.G. & Flint J. (2005). Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Molecular Psychiatry 10, 765-770. (Pubitemid 41129049)
80. Munafo M.R., Thiselton D.L., Clark T.G. & Flint J. (2006). Association of the NRG1 gene and schizophrenia: a meta-analysis. Molecular Psychiatry 11, 539-546.
81. Murray RM., Sham P., Van Os J., Zanelli J., Cannon M. & McDonald C. (2004). A developmental model for similarities and dis-similarities between schizophrenia and bipolar disorder. Schizophrenia Research 71, 405-416. (Pubitemid 39330519)
82. Norton N. Williams H.J. & Owen M.J. (2006). An update on the genetics of schizophrenia. Current Opinion in Psychiatry 19, 158-164.
83. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., Ozaki N., Taguchi T., Tatsumi M., Kamijima K., Straub R.E., Weinberger D.R., Kunugi H. & Hashimoto R. (2004). Evidence of novel neuronal functions of dysbindin. a susceptibility gene for schizo-phrenia. Human Molecular Genetics 13, 2699-2708. (Pubitemid 39485418)
84. Owen M.J., Craddock N. & Jablensky A. (2007). The genetic decon-struction of psychosis. Schizophrenia Bulletin 33, 905-911.
85. Penner J.D. & Brown A. S. (2007). Prenatal infectious and nutrition-al factors and risk of adult schizophrenia. Expert Review on Neurotherapeutics 7, 797-805.
86. Peralta V. & Cuesta M.J. (2000). Clinical models of schizophrenia: a critical approach to competing conceptions. Psychopathology 33, 252-258.
87. Peralta V. & Cuesta M.J. (2003). The diagnosis of schizophrenia: old wine in new bottles. International Journal of Psychology and Psychological Therapy 3, 141-152.
88. Peralta V., Cuesta M.J. & de Leon J. (1994). An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syn-drome model. Biological Psychiatry 36, 726-736. (Pubitemid 24365879)
89. Raybould R., Green E.K., MacGregor S., Gordon-Smith K., Heron J., Hyde S., Caesar S., Nikolov I., Williams N., Jones L., O'Donovan M.C., Owen M.J., Jones I., Kirov G. & Craddock. N. (2005). Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biological Psychiatry 57, 696-701. (Pubitemid 40487912)
90. Read J., Van Os J., Morrison A.P. & Ross C.A. (2005). Childhood trauma, psychosis and schizophrenia: a literature review with theoreti-cal and clinical implications. Acta Psychiatrica Scandinavica 112, 330-350. (Pubitemid 41564319)
91. Rietkerk T., Boks M.P., Sommer I.E., Liddle P.F., Ophoff R.A. & Kahn R.S. (2008). The genetics of symptom dimensions of schizophre-nia: review and meta-analysis. Schizophrenia Research 102, 197-205.
92. Rosenman S., Korten A., Medway J. & Evans M. (2003). Dimensional vs. categorical diagnosis in psychosis. Acta Psychiatrica Scandinavica 107, 378-384
93. Ruggeri M., Lasalvia A., Tansella M., Bonetto C., Abate M., Thornicroft G., Allevi L. & Ognibene P. (2004). Heterogeneity of out-comes in schizophrenia. 3-year follow-up of treated prevalent cases. British Journal of Psychiatry 184, 48-57. (Pubitemid 38085214)
94. Ruggeri M., Nosè M., Bonetto C., Cristofalo D., Lasalvia A., Salvi G., Stefani B., Malchiodi F. & Tansella M. (2005). Changes and pre-dictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. British Journal of Psychiatry 187, 121-130. (Pubitemid 41139683)
95. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Bucceola N.G., Mowry BJ., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cioninger C.R., Martinez M. & Gejman P.V. (2008). No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: impli-cations for psychiatric genetics. American Journal of Psychiatry 165, 497-506. (Pubitemid 351694293)
96. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W. & Wildenauer D.B. (2003). Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. American Journal of Human Genetics 72, 185-190. (Pubitemid 36056855)
97. Serretti A., Lattuada E., Lorenzi C., Lilli R. & Smeraldi E. (2000). Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Molecular Psychiatry 5, 270-274. (Pubitemid 30438402)
98. Serretti A., Lilli R., Lorenzi C., Lattuada E. & Smeraldi E. (2001). DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2, 011 affected subjects. American Journal of Human Genetics 105, 283-290. (Pubitemid 32410904)
99. Shenton M.E., Dickey C.C., Frumin M. & McCarley R.W. (2001). A review of MRI findings in schizophrenia. Schizophrenia Research 49, 1-52.
100. St Clair D. (2009). Copy number variation and schizophrenia. Schizophrenia Bulletin 35, 9-12.
101. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp .I.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling L, Moller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Muhleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney LA., Franke B., Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nothen M.M., Peltonen L., Collier D.A., St Cloud D. & Stefansson K. (2008). Large recurrent microdeletions associated with schizophrenia. Nature 455, 232-236.
102. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A, Wang X., O'Neill F.A., Walsh D. & Kendler K.S. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics 71, 337-348. (Pubitemid 34800250)
103. Strauss J.S. & Carpenter W.T, Jr. (1977). Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Archives of General Psychiatry 34, 159-163.
104. Strauss J.S., Carpenter W.T., Jr. & Bartko J.J. (1974). The diagno-. sis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophrenia Bulletin 11, 61-69.
105. Sullivan P.F. (2008). The dice are rolling for schizophrenia genetics. Psychological Medicine 38, 1693-1696.
106. Sullivan P.F., Kendler K.S. & Neale M.C. (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60, 1187-1192.
107. Tamminga C.A. & Holcomb H.H. (2005). Phenotype of schizophre-nia: a review and formulation. Molecular Psychiatry 10, 27-39.
108. Tang J.X., Zhou J., Fan J.B., Li X.W., Shi Y.Y., Gu N.F., Feng G.Y., Xing Y.L., Shi .T.G. & He L. (2003). Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Molecular Psychiatry 8, 717-718.
109. Tosato S., Dazzan P. & Collier D. (2005). Association between the neuregulin 1 gene and schizophrenia: a systematic review. Schizophrenia Bulletin 31, 613-617. (Pubitemid 41253313)
110. Tosato S., Ruggeri M., Bonetto C., Bertani M., Marrella G., Lasalvia A., Cristofalo D., Aprili G., Tansella M., Dazzan P., Diforti M., Murray R.M. & Collier DA. (2007). Association study of dys-bindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. American Journal of Medical Genetics, Part B. Neuropsychiatric Genetics 144B, 647-659. (Pubitemid 47077150)
111. Tsuang M.T. & Faraone S.V. (1995). The case for heterogeneity in the etiology of schizophrenia. Schizophrenia Research 17, 161-175.
112. van den Oord E.J., Sullivan P.F., Jiang Y., Walsh. D., O'Neill F.A., Kendler K.S. & Riley B.P. (2003). Identification of a high-risk haplo-type for the dystrobrevin binding protein 1 (DTNBPl) gene in the Irish study of high-density schizophrenia families. Molecular Psychiatry 8, 499-510. (Pubitemid 36829692)
113. Van Os J., Hanssen M., Bak M., Bijl R. V. & Voilebergh W. (2003). Do urbanicity and familial liability coparticipate in causing psychosis? American Journal of Psychiatry 160, 477-482. (Pubitemid 41094255)
114. Van Os J., Pedersen C.B. & Mortensen P.B. (2004). Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. American Journal of Psychiatry 161, 2312-2314. (Pubitemid 39587300)
115. Van Os J., Rutten B.P. & Poulton R. (2008). Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia Bulletin 34, 1066-1082.
116. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C, Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C. & Sebat J. (2008). Rare structural vari-ants disrupt multiple genes in neurodevelopmental pathways in schizo-phrenia. Science 320, 539-543. (Pubitemid 351590668)
117. Welcome Trust Case Control Consortium (2007). Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447, 661-678.
118. Weiser M., Van Os J. & Davidson M. (2005). Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endopheno-types. British Journal of Psychiatry 187, 203-205. (Pubitemid 41306099)
119. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira MA., Green T., Platt O.S., Ruderfer D.M., Walsh C.A., Altshuler D., Chakravarti A., Tanzi R.E., Stefansson K., Santangelo S.L., Gusella J.F., Sklar P., Wu B.L. & Daly M.J. (2008). Association between microdeletion and microdu-plication at 16p11.2 and autism. New England Journal of Medicine 358, 667-675. (Pubitemid 351240746)
120. Williams N.M., O'Donovan M.C. & Owen M.J. (2005). Is the dys-bindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophrenia Bulletin 31, 800-805.
121. Wong M.Y., Day N.E., Luan J.A., Chan K.P. & Wareham N.J. (2003). The detection of gene-environment interaction for continu-ous traits: should we deal with measurement error by bigger studies or better measurement? International Journal of Epidemiology 32, 51-57.
122. Zammit S., Allebeck P., Dalman C., Lundberg I., Hemmingson T., Owen M.J. & Lewis G. (2003). Paternal age and risk for schizophrenia. British Journal of Psychiatry 183, 405-408.